Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.

Recessive mutations in the cartilage-associated protein (CRTAP), leucine proline-enriched proteoglycan 1 (LEPRE1) and peptidyl prolyl cis-trans isomerase B (PPIB) genes result in phenotypes that range from lethal in the perinatal period to severe deforming osteogenesis imperfecta (OI). These genes encode CRTAP (encoded by CRTAP), prolyl 3-hydroxylase 1 (P3H1; encoded by LEPRE1) and cyclophilin B (CYPB; encoded by PPIB), which reside in the rough endoplasmic reticulum (RER) and can form a complex involved in prolyl 3-hydroxylation in type I procollagen. CYPB, a prolyl cis-trans isomerase, has been thought to drive the prolyl-containing peptide bonds to the trans configuration needed for triple helix formation. Here, we describe mutations in PPIB identified in cells from three individuals with OI. Cultured dermal fibroblasts from the most severely affected infant make some overmodified type I procollagen molecules. Proα1(I) chains are slow to assemble into trimers, and abnormal procollagen molecules concentrate in the RER, and bind to protein disulfide isomerase (PDI) and prolyl 4-hydroxylase 1 (P4H1). These findings suggest that although CYPB plays a role in helix formation another effect is on folding of the C-terminal propeptide and trimer formation. The extent of procollagen accumulation and PDI/P4H1 binding differs among cells with mutations in PPIB, CRTAP and LEPRE1 with the greatest amount in PPIB-deficient cells and the least in LEPRE1-deficient cells. These findings suggest that prolyl cis-trans isomerase may be required to effectively fold the proline-rich regions of the C-terminal propeptide to allow proα chain association and suggest an order of action for CRTAP, P3H1 and CYPB in procollagen biosynthesis and pathogenesis of OI.

[1]  David Y. Thomas,et al.  Structural Basis of Cyclophilin B Binding by the Calnexin/Calreticulin P-domain*♦ , 2010, The Journal of Biological Chemistry.

[2]  P. Lapunzina,et al.  Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. , 2010, American journal of human genetics.

[3]  P. Byers,et al.  Generalized Connective Tissue Disease in Crtap-/- Mouse , 2010, PloS one.

[4]  P. Byers,et al.  Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. , 2010, American journal of human genetics.

[5]  R. Raines,et al.  Prolyl 4-hydroxylase , 2010, Critical reviews in biochemistry and molecular biology.

[6]  C. Rotimi,et al.  Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. , 2010, The New England journal of medicine.

[7]  P. Byers,et al.  Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. , 2010, American journal of human genetics.

[8]  Wei-zhong Chang,et al.  Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. , 2010, Human molecular genetics.

[9]  H. R. Bergen,et al.  Severe Osteogenesis Imperfecta in Cyclophilin B–Deficient Mice , 2009, PLoS genetics.

[10]  D. Eyre,et al.  Location of 3-Hydroxyproline Residues in Collagen Types I, II, III, and V/XI Implies a Role in Fibril Supramolecular Assembly* , 2009, The Journal of Biological Chemistry.

[11]  G. Pals,et al.  PPIB mutations cause severe osteogenesis imperfecta. , 2009, American journal of human genetics.

[12]  Y. Ishikawa,et al.  Biochemical Characterization of the Prolyl 3-Hydroxylase 1·Cartilage-associated Protein·Cyclophilin B Complex* , 2009, The Journal of Biological Chemistry.

[13]  P. Kwok,et al.  Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype–phenotype relationships , 2008, Human molecular genetics.

[14]  G. Mortier,et al.  Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation , 2008, Journal of Medical Genetics.

[15]  John J. Mitchell,et al.  CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta , 2008, Human mutation.

[16]  R. Raines,et al.  Conformational preferences of substrates for human prolyl 4-hydroxylase. , 2008, Biochemistry.

[17]  D. Bannasch,et al.  Homozygosity mapping approach identifies a missense mutation in equine cyclophilin B (PPIB) associated with HERDA in the American Quarter Horse. , 2007, Genomics.

[18]  F. Glorieux,et al.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans , 2007, Human mutation.

[19]  C. Tifft,et al.  Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta , 2007, Nature Genetics.

[20]  J. Mulvihill,et al.  Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. , 2006, The New England journal of medicine.

[21]  F. Glorieux,et al.  CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta , 2006, Cell.

[22]  R. Raines,et al.  Reciprocity of steric and stereoelectronic effects in the collagen triple helix. , 2006, Journal of the American Chemical Society.

[23]  R. Bank,et al.  Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2 , 2004, American journal of medical genetics. Part A.

[24]  L. Sakai,et al.  Prolyl 3-Hydroxylase 1, Enzyme Characterization and Identification of a Novel Family of Enzymes* , 2004, Journal of Biological Chemistry.

[25]  P. Byers,et al.  Gene Targeting in Stem Cells from Individuals with Osteogenesis Imperfecta , 2004, Science.

[26]  P. Byers,et al.  Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proα1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta , 2001, Journal of medical genetics.

[27]  K. McCarthy,et al.  Molecular Characterization of a Novel Basement Membrane-associated Proteoglycan, Leprecan* , 1999, The Journal of Biological Chemistry.

[28]  C. Wijmenga,et al.  Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Sillence,et al.  Endoplasmic Reticulum-mediated Quality Control of Type I Collagen Production by Cells from Osteogenesis Imperfecta Patients with Mutations in the proα1(I) Chain Carboxyl-terminal Propeptide which Impair Subunit Assembly (*) , 1995, The Journal of Biological Chemistry.

[30]  P. Byers,et al.  Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta. , 1993, The Journal of biological chemistry.

[31]  N. Morris,et al.  Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. , 1993, American journal of medical genetics.

[32]  M. Godbout,et al.  An endoplasmic reticulum-specific cyclophilin , 1991, Molecular and cellular biology.

[33]  C. Walsh,et al.  Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Superti-Furga,et al.  Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. , 1991, The Journal of biological chemistry.

[35]  N. Tuross,et al.  The Mr 24,000 phosphoprotein from developing bone is the NH2-terminal propeptide of the alpha 1 chain of type I collagen. , 1987, The Journal of biological chemistry.

[36]  J. Koivu.  Identification of disulfide bonds in carboxy‐terminal propeptides of human type I procollagen , 1987, FEBS letters.

[37]  P. Byers,et al.  Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. , 1985, The Journal of biological chemistry.

[38]  P. Byers,et al.  Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta. , 1984, The Journal of biological chemistry.

[39]  D. Torchia,et al.  Detection of cis and trans X-Pro peptide bonds in proteins by 13C NMR: application to collagen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Timpl,et al.  The Role of Cis-Trans Isomerization of Peptide Bonds in the Coil ⇄ Triple Helix Conversion of Collagen , 1978 .

[41]  R. Timpl,et al.  The role of cis-trans isomerization of peptide bonds in the coil leads to and comes from triple helix conversion of collagen. , 1978, European journal of biochemistry.

[42]  R A Berg,et al.  The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen. , 1973, Biochemical and biophysical research communications.